Table 1.
Species | Bioactive Compounds/ Extracts/ Purified Compounds |
Model | Anti-Inflammatory Activity | Ref. |
---|---|---|---|---|
Eisenia bicyclis | Phlorofucofuroeckol A (compound purified by HPLC and characterized by NMR). | Lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. |
Suppresses LPS-induced nitric oxide (NO) production at 10 µg/mL. In this study, 10 µM AMT 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine was used as a positive control. |
[22] |
Ecklonia
stolonifera |
Phlorofucofuroeckol B (compound purified by HPLC and characterized by NMR). | LPS-stimulated microglial cells. |
Inhibits secretion of tumor necrosis factor (TNF) -α, interleukin (IL)-1β and IL-6, downregulates the transcription of cycloxygenase (COX)-2 and iNOS synthase, inhibits IκB-α/NF-κB and Akt/ERK/JNK pathways at concentrations of 10 µM–40 µM. | [23] |
Ecklonia
cava |
Dieckol (compound purified by HPLC and characterized by NMR). | LPS-stimulated microglial cells. |
Suppresses LPS-induced mRNA expression of inflammatory mediators COX-2 and iNOS and NO production at concentrations 50 µg/mL to 300 µg/mL. Inhibits IL-1β and TNFα production. Reduces mRNA expression of NF-κB and p38 MAPK. | [24] |
Ecklonia
cava |
Dieckol (commercial dieckol is used in this study). |
Carrageenan-triggered inflammation in mice. | Dieckol inhibits carrageenan-triggered inflammation, leukocyte infiltration and formation of pro-inflammatory regulators such as TNFα, IL1β, IL6, etc. at dosages from 5 mg/kg–20 mg/kg bodyweight. | [25] |
Ishige
okamurae |
Diphloretho- hydroxycarmalol purified from aqueous methanol extract through HPLC and characterized by NMR. |
LPS-induced RAW 264.7 cells and TNF-α-stimulated C2C12 myotubes. |
Downregulates mRNA expression of pro-inflammatory cytokines, reduces NO production and reduces protein expression of NF-κB and p38 MAPK at concentration ranges from 6 to 200 µg/mL. | [26] |
Ishige
okamurae |
Diphloretho- hydroxycarmalol purified from aqueous methanol extract through HPLC and characterized by NMR. |
LPS-stimulated RAW 264.7 macrophages. |
Downregulates IκB-α and NF-κB protein expression and inhibits IL-6 production by downregulating STAT5 activation and SOCS1 augmentation at concentration ranges from 12.5 to 100 µM. | [27] |
Ishige
foliacea |
Octaphlorethol A purified from aqueous ethanolic extract and characterized by LC/MS and NMR. | CpG- stimulated C57BL/6 mice bone-marrow-derived macrophages and bone-marrow-derived dendritic cells. | Exhibits anti-inflammatory activity by octaphlorethol A by transcriptional regulation of NF-κB through MAPK at concentration ranges from 1.5 to 50 µM. | [28] |
Saccharina
japonica |
Fucoidan purified from ethanolic extract by dialysis and HPLC. | LPS-stimulated RAW 264.7 macrophages and LPS-induced zebrafish embryonic cells. |
Reduces the production of NO and downregulates the expression of MAPK (including p38, ENK and JNK) and NF-κB (including p65 and IκBα/ IκBβ) signaling pathways at concentration ranges from 12.5 to 50 µg/mL. | [29] |
Colpomenia
sinuosa |
Fucoidan purified from ethanol:formaldehyde:water solvent system through acid extraction and purification. |
In vitro NO scavenging assay and RBC hemolysis and PCM-induced hepatic injury in rat. |
Prevents paracetamol-induced hepatic oxidative stress and decreases NO, iNOS, TNFα, IL-1β and IL-6 in liver tissue at a concentration of 10 to 50 µg/mL. | [30] |
Fucus
vesiculosus |
Fucoidan from Fucus vesiculosus purchased from Sigma. | LPS-stimulated RAW 264.7 macrophages and LPS-induced zebrafish embryonic cells. |
Decreases secretion of NO, prostaglandin (PG) E2, TNFα and IL-1β at concentration ranges from 0.5 to 10 µg/mL. | [31] |
Fucus vesiculosus | Fucoidan crude hot water extract. | UV-induced inflammation in HaCaT cells. |
Decreases production of NO, PGE2, IL-1β and TNFα, and inhibits NF-κB, Akt, ERK, p38 MAPK and JNK pathways regulated by nc886-PKR. | [32] |
Sargassum
fulvellum |
Sulfated polysaccharides purified from ethanolic extract by HPLC. |
LPS-stimulated RAW 264.7 macrophages and LPS-induced zebrafish embryonic cells. |
Suppresses production of NO, TNFα, IL-1β and IL-6, downregulates expression of iNOS and COX-2 in LPS-stimulated RAW 264.7 cells, improves survival rate and reduces cell death, reactive oxygen species (ROS) and NO in LPS-stimulated zebrafish at concentration ranges from 25 to 100 µg/mL. |
[33] |
Sargassum
horneri |
Alginic acid purified from ethanolic extract by HPLC and GC/MS. | LPS-stimulated RAW 264.7 and human haCaT cells and particulate-matter-stimulated inflammation in keratinocytes and fibroblasts | Suppresses PGE2 production via COX-2 inhibition, decreases pro-inflammatory cytokines and abates NF-κB and MAPK pathways in the model system at concentration ranges from 50 to 125 µg/mL. | [34] |
Grifola
frondosa |
Laminarin purified from water extract by dialysis. | LPS-stimulated RAW 264.7 macrophages. |
Inhibits NO and PGE2 production, suppresses pro-inflammatory cytokine (TNF-α and IL-6) secretion and inactivates NF-κB pathway at concentration ranges from 50 to 200 µg/mL. | [35] |
Padina
boryana |
Fucosterol purified from ethanolic extract by HPLC. | Particulate matter and LPS-stimulated RAW 264.7 macrophages. |
Inactivates NF-kB and MPAK pathways and suppresses iNOS, COX-2, pro-inflammatory cytokines and PGE2 mRNA expression at concentration ranges from 12.5 to 50 µg/mL. |
[36] |
Stypopodium flabelliforme | Epitaondiol purified from marine metabolite. | In vitro sPLA2 activity, 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema model. | Inhibits phospholipase A2 production, suppresses eicosanoid (LTB4 and TXB2) release and reduces TPA-induced mouse ear inflammation at approximately 3.8 µM. |
[37] |
Laurencia
glandulifera |
Neorogioltriol purified from many solvent fractions by HPLC. | LPS-stimulated RAW 264.7 macrophages, DSS-induced colitis in mice. |
Suppresses macrophage activation, promotes M2-like anti-inflammatory phenotype and suppresses DSS-induced colitis by reducing tissue damage and pro-inflammatory cytokine production. |
[38] |
Dunaliella tertiolecta | Ergosterol purified from lipid extract by HPLC and analyzed by GC/MS. | LPS- and ConA-stimulated sheep peripheral blood mononuclear cells. | Inhibits pro-inflammatory cytokines (TNF-α, IL-6, IL-1β and IL-10) production at concentration of 0.2 to 0.8 mg/mL. |
[39] |
Sargassum
muticum |
Apo-9′-fucoxanthinone. | LPS-stimulated RAW 264.7 macrophages and LPS-induced zebrafish embryonic cells. |
Suppresses mRNA expression of inflammatory mediators such as iNOS, COX-2 and pro inflammatory cytokines, and modulates NF-κB and MPAK signaling pathways | [40] |
Amansia
multifida |
Lectin purified by sodium salt extraction and HPLC. | Carrageenan-triggered inflammation models in rat. | Reduces parameters of the inflammatory process such as edema formation and leukocyte migration, and modulates levels of proinflammatory cytokines, IL-1β and TNF-α. | [41] |
Bryothamnion
triquetrum |
Lectin. | Carrageenan-triggered inflammation in rat. | Inhibits vascular and cellular events of an acute inflammatory response, and inhibits neutrophil migration to inflammation sites via suppression of TNF-α and IL-1β production at different concentrations in different models. |
[42] |
Ulva spp. | Peptide fractions purified from enzyme hydrolysate and characterized by FPLC. | LPS and ConA-stimulated rat spleen mononuclear cells. | Modulates TLR4 and the NFκB/p38/JNK pathway at 0.01 g/L to 0.1g/L. |
[43] |
Caulerpa peltata, Caulerpa racemosa |
Caulerpin purified from ethanolic extract and crystalized from liquid portioning. | DSS-induced colitis in mice. | Reduces inflammatory infiltrates and the levels of the proinflammatory cytokines, increases the levels of the anti-inflammatory cytokine IL-10 and suppresses NF-κB p65 expression. |
[44] |
Gracilaria
opuntia |
Azocinyl morpholinone alkaloid purified from ethanol:methanol extract by HPLC. | Carrageenan-triggered inflammation in rat. In vitro anti-inflammatory model using 5-LOX inhibition assay. | Reduces edema formation by 6 h and exhibits a selective inhibitory effect on COX-2 and 5-LOX activity at a concentration of approximately 0.08 mg/mL. | [45] |
Ulva
pertusa |
3-Hydroxy-4,7-megastigmadien-9-one purified from aqueous ethanol extract by MPLC. | CpG-stimulated C57BL/6 mice bone-marrow-derived dendritic cells. | Inhibits IL-12 p40, IL-6 and TNF-α production and blocks MAPKs and NF-κB pathways at concentration ranges from 0.1 to 50 µM. | [46] |
Laelia
undulata |
Floridoside purified from methanolic extract by thin-layer chromatography. | LPS-stimulated BV-2 microglia cells. | Inhibits the production of NO and ROS and downregulates the protein and gene expression levels of iNOS and COX-2 by significantly blocking the phosphorylation of p38 and ERK in LPS-stimulated BV-2 cells at concentration ranges from 10 to 50 µM. | [47] |
Cymopolia
barbata |
Cymopol and cyclocymopol purified from various non-polar extract through HPLC. | DSS-induced colitis in mice, zebrafish tail wound model and RAW 264.7 macrophages. | Attenuates neutrophil migration and reduces the colon inflammation at the in vitro concentration of 1 to 3 µM and 0.1 to 0.4 g/kg body weight. | [48] |
Sargassum
siliquastrum |
Sargachromanol G isolated from aqueous methanol and other solvent and then purified from HPLC. | LPS- and RANKL-stimulated RAW 264.7 macrophages |
Reduces the expression of pro-inflammatory cytokines, suppresses NO and PGE2 production via inhibition of iNOS and COX-2 and inhibits RANKL-induced activation of NF-κB by suppressing RANKL-mediated IκB-α degradation at concentration ranges from 10 to 40 µM. | [49,50] |